Immunogenicity and Therapeutic Efficacy of Dendritic–Tumor Hybrid Cells Generated by Electrofusion

This publication has 19 references indexed in Scilit:

• Ox40 Costimulation Enhances the Development of T Cell Responses Induced by Dendritic Cells In Vivo
  The Journal of Immunology, 2002
• Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor
  The Journal of Immunology, 2001
• Active immunization against cancer with dendritic cells: the near future.
  International Journal of Cancer, 2001
• Antitumor Effect of Immunizations With Fusions of Dendritic and Glioma Cells in a Mouse Brain Tumor Model
  Journal of Immunotherapy, 2001
• Helper-Independent, L-Selectinlow CD8+ T Cells with Broad Anti-Tumor Efficacy Are Naturally Sensitized During Tumor Progression
  The Journal of Immunology, 2000
• Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells
  Proceedings of the National Academy of Sciences, 2000
• Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity
  International Journal of Cancer, 1998
• Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified.
  The Journal of Experimental Medicine, 1996
• IL‐12‐Engineered Dendritic Cells Serve as Effective Tumor Vaccine Adjuvants in Vivoa
  Annals of the New York Academy of Sciences, 1996
• [14] Electrofusion
  Published by Elsevier ,1993